Fields »
ABOUT
HELP
BLOG

646 GENES FOUND

Show / hide columns

XML | RDF | TSV | Page of 13 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

 

 

Subcellular location

x

 

 

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
ABAT4-aminobutyrate aminotransferaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
MitochondriaTissue enhanced
ABCA1ATP-binding cassette, sub-family A (ABC1), member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Nucleoplasm
Vesicles		Mixed
ABCC1ATP-binding cassette, sub-family C (CFTR/MRP), member 1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Plasma membraneMixed
ABCC2ATP-binding cassette, sub-family C (CFTR/MRP), member 2Cancer-related genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Group enriched
ABCC8ATP-binding cassette, sub-family C (CFTR/MRP), member 8Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Nucleoli
Golgi apparatus
Cytosol		Tissue enhanced
ABL1ABL proto-oncogene 1, non-receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Nucleoplasm
Nuclear bodies		Expressed in all
ACAA1Acetyl-CoA acyltransferase 1Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
PeroxisomesExpressed in all
ACEAngiotensin I converting enzymeCandidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
VesiclesTissue enhanced
ACE2Angiotensin I converting enzyme 2Enzymes
FDA approved drug targets
Predicted membrane proteins
Group enriched
ACHEAcetylcholinesterase (Yt blood group)Blood group antigen proteins
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles		Tissue enhanced
ADAAdenosine deaminaseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Tissue enriched
ADH1AAlcohol dehydrogenase 1A (class I), alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Tissue enriched
ADH1BAlcohol dehydrogenase 1B (class I), beta polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Group enriched
ADH1CAlcohol dehydrogenase 1C (class I), gamma polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoplasm
Plasma membrane
Cytosol		Tissue enhanced
ADKAdenosine kinaseDisease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol		Expressed in all
ADORA1Adenosine A1 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Plasma membraneTissue enhanced
ADORA2AAdenosine A2a receptorCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ADORA2BAdenosine A2b receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
CytosolMixed
ADORA3Adenosine A3 receptorFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA1AAdrenoceptor alpha 1AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRA1BAdrenoceptor alpha 1BCancer-related genes
FDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
ADRA1DAdrenoceptor alpha 1DFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
ADRA2AAdrenoceptor alpha 2AFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Mixed
ADRA2CAdrenoceptor alpha 2CFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB1Adrenoceptor beta 1FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
ADRB2Adrenoceptor beta 2, surfaceFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
CytosolMixed
ADRB3Adrenoceptor beta 3FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Tissue enhanced
AGTR1Angiotensin II receptor, type 1Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
VesiclesTissue enhanced
AKR1C2Aldo-keto reductase family 1, member C2Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleus
Nucleoli fibrillar center
Endoplasmic reticulum
Cytosol		Group enriched
AKR1D1Aldo-keto reductase family 1, member D1Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Cytosol		Tissue enriched
ALADAminolevulinate dehydrataseDisease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
ALDH2Aldehyde dehydrogenase 2 family (mitochondrial)Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Expressed in all
ALKAnaplastic lymphoma receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneTissue enhanced
ALOX5Arachidonate 5-lipoxygenaseEnzymes
FDA approved drug targets
Predicted intracellular proteins
NucleoplasmTissue enhanced
ALPPL2Alkaline phosphatase, placental-like 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
Plasma membraneTissue enhanced
AMY2AAmylase, alpha 2A (pancreatic)Enzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
ANO1Anoctamin 1, calcium activated chloride channelFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Tissue enhanced
ANXA1Annexin A1Cancer-related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Transporters
Nucleoplasm
Plasma membrane
Cytosol		Tissue enriched
AOC3Amine oxidase, copper containing 3Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Golgi apparatus
Cytosol		Tissue enhanced
APEX1APEX nuclease (multifunctional DNA repair enzyme) 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
NucleusExpressed in all
ARAndrogen receptorCancer-related genes
Disease related genes
FDA approved drug targets
Nuclear receptors
Plasma proteins
Predicted intracellular proteins
Transcription factors
MitochondriaMixed
ASIC1Acid sensing (proton gated) ion channel 1FDA approved drug targets
Predicted membrane proteins
Golgi apparatus
Plasma membrane		Tissue enriched
ATIC5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol		Expressed in all
ATP1A1ATPase, Na+/K+ transporting, alpha 1 polypeptideCancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Expressed in all
ATP2C1ATPase, Ca++ transporting, type 2C, member 1Disease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
Transporters
Golgi apparatusExpressed in all
ATP4AATPase, H+/K+ exchanging, alpha polypeptideEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Tissue enriched
ATP6V1B2ATPase, H+ transporting, lysosomal 56/58kDa, V1 subunit B2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Transporters
VesiclesExpressed in all
AVPR1AArginine vasopressin receptor 1AFDA approved drug targets
G-protein coupled receptors
Plasma proteins
Predicted membrane proteins
Tissue enhanced
AVPR1BArginine vasopressin receptor 1BFDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Not detected
AVPR2Arginine vasopressin receptor 2Disease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted membrane proteins
Transporters
Tissue enhanced

Page of 13 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.